These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 233359)

  • 41. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
    Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
    [No Abstract]   [Full Text] [Related]  

  • 42. [An approach to discovering patients with nasopharyngeal carcinoma by detection of EB virus VCA-IgA antibody].
    Li SJ; Yuan H; Gao XK; Zhou HY; Su CL; Liu YH; Lin DC
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Jun; 19(2):161-3. PubMed ID: 3058573
    [No Abstract]   [Full Text] [Related]  

  • 43. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
    Pavelka R; Popow-Kraupp T; Radaszkiewicz T
    Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr-specific IgA in nasopharyngeal cancer.
    Lancet; 1978 Jun; 1(8078):1345-6. PubMed ID: 78104
    [No Abstract]   [Full Text] [Related]  

  • 49. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
    Nadala EC; Tan TM; Wong HM; Ting RC
    J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
    J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
    Ho HC; Ng MH; Kwan HC
    Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619
    [No Abstract]   [Full Text] [Related]  

  • 53. [Diagnostic evaluation of anti-EBV(VCA and EA) antibody titration in patients with nasopharyngeal carcinoma (author's transl)].
    Takimoto T
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Mar; 82(3):255-62. PubMed ID: 228017
    [No Abstract]   [Full Text] [Related]  

  • 54. Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period.
    Ho S; Teo P; Kwan WH; Choi P; Tjong J; Johnson PJ
    Oral Oncol; 1998 Nov; 34(6):491-5. PubMed ID: 9930360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma.
    Yi Z; Yuxi L; Chunren L; Sanwen C; Jihneng W; Jisong Z; Huijong Z
    Intervirology; 1980; 13(3):162-8. PubMed ID: 6246033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relationship between changes of 3 types of anti-EB virus antibodies in the serum of patients with nasopharyngeal cancer and their clinical courses].
    Terayama Y; Ueno M; Kamata N; Jinnai I; Sasaki Y
    Nihon Jibiinkoka Gakkai Kaiho; 1972 Oct; 75(10):1079-80. PubMed ID: 4120228
    [No Abstract]   [Full Text] [Related]  

  • 57. [Superinfection of human lymphoblastoid cells with EB virus (author's transl)].
    Vlcková I; Vonka V
    Cesk Epidemiol Mikrobiol Imunol; 1975 Jan; 24(1):3-8. PubMed ID: 165904
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-EB virus titer in serum of patients with otorhinolaryngology cancer].
    Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Sep; 73(9):1533-6. PubMed ID: 4319400
    [No Abstract]   [Full Text] [Related]  

  • 59. Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology.
    Huang DP; Ho HC; Henle W; Henle G; Saw D; Lui M
    Int J Cancer; 1978 Sep; 22(3):266-74. PubMed ID: 212372
    [No Abstract]   [Full Text] [Related]  

  • 60. EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions.
    De Schryver A; Klein G; Henle G; Henle W; Cameron HM; Santesson L; Clifford P
    Int J Cancer; 1972 Mar; 9(2):353-64. PubMed ID: 4339412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.